Beteiligungsmeldung
GEM Global Yield LLC SCS
Declared position
3%
Threshold
Fell below threshold
Timeline
Published
17.09.2026
Transaction
02.06.2025
Voting rights breakdown
Notice details
Meldungs-ID
ZA01-000000000SMV2
Beneficial owner
GEM Global Yield LLC SCS
Gemeldete Adresse
GEM GLOBAL YIELD LLC SCS, Luxembourg, LU
Pursuant to a Share Subscription Facility agreement ("SSF") effective April 10, 2023, GEM committed to provide up to CHF 57 million to Kinarus Therapeutics Holding AG in exchange for registered shares of Kinarus Therapeutics Holding AG, par value CHF 0.01 each (the "Shares"), until June 3, 2025, at the discretion of Kinarus Therapeutics Holding AG, subject to certain exceptions and limitations. NO SHARES WERE ISSUED UNDER THIS FACILTY TO KINARUS OR ITS SUCCESSOR COMPANY CURATIS
insider24.ch
Verpassen Sie kein Marktsignal mehr
Mehr benötigt? Pro-Angebot entdecken